Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...
Reexamination Certificate
2007-09-04
2007-09-04
Rawlings, Stephen L. (Department: 1643)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Animal cell, per se, expressing immunoglobulin, antibody, or...
C530S387100, C530S387300, C530S388100, C424S143100
Reexamination Certificate
active
10432236
ABSTRACT:
The present invention provides an antibody which specifically recognizes an epitope containing a part of a domain based on a finding that the domain ranging from the 269- to 315-positions of human CD14 represented by SEQ ID NO:1 is a site capable of interacting with another protein, an antibodies provided. This antibody can inhibit the interaction between human CD14 and another protein and thus suppress cell activation. And also, the present invention provides hybridomas producing the above antibody or its fragment; a peptide containing the amino acids in the domain as specified above; a method of constructing an antibody with the use of this peptide as an immunogen; and a method of screening a medicament for sepsis involving the step of bringing a test substance into contact with CD14 and TLR.
REFERENCES:
patent: 5730980 (1998-03-01), Ulevitch et al.
patent: 2004/0092712 (2004-05-01), Furusako et al.
patent: 0 911 400 (1999-04-01), None
patent: 8-510909 (1996-11-01), None
patent: 10-505839 (1998-06-01), None
patent: WO9101639 (1991-02-01), None
patent: WO94/28025 (1994-12-01), None
patent: WO94/28025 (1994-12-01), None
patent: WO95/31562 (1995-11-01), None
patent: WO96/08272 (1996-03-01), None
patent: WO96/20957 (1996-07-01), None
patent: WO98/39438 (1998-09-01), None
Paul W. ed. Fundamental Immunology, 3rd edition, 1993, p. 242.
Rudikoff et al. Proc. Natl. Acad. Sci. USA 79:1979-1983 (1982).
Skerra A. Journal of Molecular Recognition 13:167-187 (2000).
Iwaki D. et al. Biochemical and Biophysical Research Communications 328: 173-176, 2005.
Ulevitch R. Crit. Care Med. 29(7): S8-S12, 2001.
Akashi, Sachiko, et al. Biochemical and Biophysical Research Communications. vol. 268, No. 1, pp. 172-177, Feb. 2000.
Hashimoto, Masahito, et al. Biochemical and Biophysical Research Communications. vol. 273, No. 1, pp. 164-169, Jun. 2000.
Tapping, Richard I. The Journal of Immunology. vol. 165, pp. 5780-5787, Nov. 15, 2000.
Schroder, Nicolas W. J. The Journal of Immunology, vol. 165, pp. 2683-2693, Sep. 2000.
M. O. Labeta et al., Eur. J. Immunol. 1993, 23:2144-2151.
S. D. Wright et al., Science, 1990, vol. 249, pp. 1431-1433.
T. S.-C. Juan et al., J. Biol. Chem., vol. 270, No. 3, pp. 1382-1387, Jan. 20, 1995.
T. S.-C. Juan et al., J. Biol. Chem., vol. 270, No. 29, pp. 17237-17242, Jul. 21, 1995.
T. S.-C. Juan et al., J. Biol. Chem., vol. 270, No. 10, pp. 5219-5224, Mar. 10, 1995.
F. L. Rock et al., Proc. Natl. Acad. Sci. USA, vol. 95, pp. 588-593, Jan. 1998.
O. Takeuchi et al., Immunity, vol. 11, pp. 443-451, Oct. 1999.
R.-B. Yang et al., Nature, vol. 395, pp. 284-288, Sep. 17, 1998.
W. C. Van Voorhis et al., J. Exp. Med., vol. 158, pp. 126-145, Jul 1983.
Bazil et al., Eur. J. Immunol., vol. 16, pp. 1583-1589, 1986.
Regine Landmann et al.; Microbes and Infection; vol. 2, No. 3; Mar. 2000; pp. 295-304; XP002277719.
Furusako Shoji
Mori Sadao
Shirakawa Kamon
Duffy Brad
Mochida Pharmaceutical Co. Ltd.
Rawlings Stephen L.
LandOfFree
Anti-CD14 monoclonal antibody having effect of inhibiting... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-CD14 monoclonal antibody having effect of inhibiting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-CD14 monoclonal antibody having effect of inhibiting... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3769928